MedPath

吉林省益浦生物科技有限公司

Ownership
-
Established
2019-09-12
Employees
-
Market Cap
-
Website
jlyipu.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

20

NMPA:20

Drug Approvals

Ibuprofen Sustained-release Capsules

Product Name
布洛芬缓释胶囊
Approval Number
国药准字H20254378
Approval Date
May 27, 2025
NMPA

Colloidal Bismuth Pectin Capsules

Product Name
胶体果胶铋胶囊
Approval Number
国药准字H20183364
Approval Date
Aug 7, 2023
NMPA

Omeprazole Enteric Capsules

Product Name
奥美拉唑肠溶胶囊
Approval Number
国药准字H20123371
Approval Date
Mar 9, 2023
NMPA

血塞通分散片

Approval Number
国药准字Z20073289
Approval Date
Nov 4, 2022
NMPA

双丹口服液

Approval Number
国药准字Z20063372
Approval Date
Jun 8, 2021
NMPA

健胃消食片

Approval Number
国药准字Z20063602
Approval Date
Nov 27, 2020
NMPA

通便灵胶囊

Approval Number
国药准字Z20053170
Approval Date
Nov 27, 2020
NMPA

乳宁片

Approval Number
国药准字Z20055392
Approval Date
Nov 27, 2020
NMPA

复方金银花颗粒

Approval Number
国药准字Z11020476
Approval Date
Nov 27, 2020
NMPA

通脉颗粒

Approval Number
国药准字Z20044014
Approval Date
Nov 27, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.